Rating To Observe: Macquarie Maintains Mediclinic International Plc (LON:MDC) As Neutral; Has Price Objective Of GBX 830.00

November 23, 2016 - By Nellie Frank

Mediclinic International Plc (LON:MDC) Rating

The firm have set target price per share of GBX 830.00 on Mediclinic International Plc (LON:MDC) shares. This is 12.89% from the previous close. In a report sent to investors on 23 November, Macquarie reconfirmed their Neutral rating on shares of MDC.

Mediclinic International PLC (LON:MDC) Ratings Coverage

Out of 10 analysts covering Mediclinic International (LON:MDC), 3 rate it a “Buy”, 1 “Sell”, while 6 “Hold”. This means 30% are positive. GBX 1170 is the highest target while GBX 745 is the lowest. The GBX 946.60 average target is 28.44% above today’s (GBX 737) stock price. Mediclinic International has been the topic of 18 analyst reports since February 18, 2016 according to StockzIntelligence Inc. On Tuesday, August 23 the stock rating was maintained by JP Morgan with “Neutral”. Investec maintained Mediclinic International PLC (LON:MDC) on Monday, March 14 with “Buy” rating. As per Tuesday, June 28, the company rating was upgraded by Citigroup. The stock has “Buy” rating given by UBS on Tuesday, September 6. Citigroup downgraded Mediclinic International PLC (LON:MDC) rating on Monday, September 12. Citigroup has “Neutral” rating and GBX 1090 price target. The rating was maintained by HSBC with “Reduce” on Friday, November 11. Macquarie Research maintained it with “Neutral” rating and GBX 900 target price in Friday, May 27 report. Jefferies maintained the stock with “Hold” rating in Tuesday, July 26 report. Macquarie Research maintained the shares of MDC in a report on Wednesday, November 23 with “Neutral” rating. As per Thursday, September 22, the company rating was maintained by Jefferies.

About 153,360 shares traded hands. Mediclinic International PLC (LON:MDC) has declined 19.73% since April 26, 2016 and is downtrending. It has underperformed by 25.05% the S&P500.

Insitutional Activity: The institutional sentiment increased to 1.22 in Q2 2016. Its up 0.39, from 0.83 in 2016Q1. The ratio is positive, as 26 funds sold all Mediclinic International PLC shares owned while 62 reduced positions. 21 funds bought stakes while 52 increased positions. They now own 38.01 million shares or 0.55% more from 37.80 million shares in 2016Q1.

D E Shaw has 0% invested in the company for 39,981 shares. Hexavest accumulated 0.21% or 557,560 shares. Blackrock accumulated 9,597 shares or 0% of the stock. Finemark Natl Bancorporation accumulated 0% or 500 shares. Teacher Retirement Systems Of Texas has 5,446 shares for 0% of their US portfolio. Moreover, New York State Teachers Retirement System has 0.01% invested in Mediclinic International PLC (LON:MDC) for 98,824 shares. Sg Americas Lc accumulated 0% or 9,714 shares. Moreover, Ameriprise has 0% invested in Mediclinic International PLC (LON:MDC) for 205,014 shares. Oppenheimer And has 32,676 shares for 0.02% of their US portfolio. Wells Fargo & Mn last reported 1.09M shares in the company. The New York-based Citigroup has invested 0% in Mediclinic International PLC (LON:MDC). State Board Of Administration Of Florida Retirement Sys owns 29,918 shares or 0% of their US portfolio. Moreover, Deere And has 0.01% invested in Mediclinic International PLC (LON:MDC) for 9,661 shares. Moreover, Johnson Fincl Gru has 0% invested in Mediclinic International PLC (LON:MDC) for 790 shares. Brandywine Global Inv Limited Co holds 0.04% of its portfolio in Mediclinic International PLC (LON:MDC) for 214,004 shares.

Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The company has a market cap of 5.43 billion GBP. The Firm operates as an international private healthcare provider. It has a 26.95 P/E ratio. The Company’s divisions include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate.

According to Zacks Investment Research, “M.D.C. HOLDINGS, INC. is engaged in the construction, sale and related financing of residential housing and the acquisition and development of land for use in its homebuilding activities and sale to others, in the Denver, Phoenix, Maryland, Virginia, mid Atlantic region, Las Vegas, Dallas, California metropolitan areas. They are also is involved in real estate brokerage, property management, condominium conversions and fee construction of apartment and commercial buildings.”

MDC Company Profile

M.D.C. Holdings, Inc., incorporated on May 17, 1985, is engaged in two primary operations, including homebuilding and financial services. The Company’s homebuilding activities consist of subsidiary companies that purchases finished lots or develop lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the name Richmond American Homes. The Company’s homebuilding activities consists of various homebuilding divisions that the Company considers to be its operating divisions. The Company’s operating divisions include West (include operating divisions located in Arizona, California, Nevada and Washington); Mountain (include operating divisions located in Colorado and Utah), and East (include operating divisions located in Virginia, Florida and Maryland, which include Pennsylvania, and New Jersey).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>